Task: Answer the multiple-choice question.
Query: Which drug exhibits a -5.395% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COc1ccc2nc(SCCC(=O)O)cc(C)c2c1
b Cl.NCCCNc1ccc([N+](=O)[O-])cc1C(F)(F)F
c Cc1ccc(/C=C(\NC(=O)c2ccccc2)C(=O)NCC2CCCO2)o1
Answer: c. Cc1ccc(/C=C(\NC(=O)c2ccccc2)C(=O)NCC2CCCO2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(/C=C(\NC(=O)c2ccccc2)C(=O)NCC2CCCO2)o1
Cc1ccc(/C=C(\NC(=O)c2ccccc2)C(=O)NCC2CCCO2)o1
N-[(Z)-1-(5-methylfuran-2-yl)-3-oxo-3-(oxolan-2-ylmethylamino)prop-1-en-2-yl]benzamide